POPADIPE: Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients

Sponsor
Centre Hospitalier le Mans (Other)
Overall Status
Recruiting
CT.gov ID
NCT06067906
Collaborator
(none)
60
1
2
60
1

Study Details

Study Description

Brief Summary

In view of the known link between pre-eclampsia, overweight/obesity and chronic kidney disease, the aim is to offer for obese and overweight patients to reduce their BMI without reducing lean body mass.

The POPADIPE project will make it possible to limit overweight or obesity by means of nutritional management chosen by the patient (hypocaloric or a dissociated diet). The latter has been the subject of little scientific investigation, particularly in relation to the management of post-pre-eclampsia.

Condition or Disease Intervention/Treatment Phase
  • Other: Hypocaloric diet
  • Other: Dissociated diet
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients
Actual Study Start Date :
Sep 14, 2023
Anticipated Primary Completion Date :
Sep 14, 2028
Anticipated Study Completion Date :
Sep 14, 2028

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: control group

Other: Hypocaloric diet
Hypocaloric diet

Experimental: innovative group

Other: Dissociated diet
Dissociated diet

Outcome Measures

Primary Outcome Measures

  1. Demonstrate Efficiency of personalised dietary management on weight loss in patients with a history of pre-eclampsia [1 year after care]

    Efficiency is evaluated by weight measurement

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Person affiliated to social security

  • Free, informed and written consent signed by the participant and the investigator (no later than the day of day of inclusion and before any examination required by the research)

  • Patient over 18 years of age at the time of inclusion and < 45 years of age

  • Having had an pre-eclampsia in the last 5 years according to the definitions of the ISSHP 2018

  • Patient with a BMI between 25 kg/m² and 40 kg/m² who accepts dietetic follow up

  • Patient with a medical prescription for dietetic follow-up aimed at losing weight loss

  • Patient with a balanced diet

Exclusion Criteria:
  • Patients with a mental disability or language barrier that prevents them from understanding or consenting to the study

  • Patients deprived of their liberty by judicial or administrative decision

  • Patients under psychiatric care

  • Patients subject to a legal protection measure

  • Patients with cognitive disorders or defined eating disorders

  • Patients who are pregnant or breast-feeding

  • Patients undergoing steroid treatment and/or immunosuppression

  • Have been on a low-calorie or dissociated diet for at least 6 months

  • Patients with CKD stage ≥ 3A

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Du Mans Le Mans France 72000

Sponsors and Collaborators

  • Centre Hospitalier le Mans

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier le Mans
ClinicalTrials.gov Identifier:
NCT06067906
Other Study ID Numbers:
  • CHM-2022/S08/12
First Posted:
Oct 5, 2023
Last Update Posted:
Oct 5, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier le Mans
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2023